Arcus Biosciences Inc (NYSE:RCUS)
$ 16 0.16 (1.01%) Market Cap: 1.46 Bil Enterprise Value: 456.70 Mil PE Ratio: 0 PB Ratio: 2.06 GF Score: 75/100

Arcus Biosciences Inc at Citi BioPharma Conference (Virtual) Transcript

Sep 10, 2021 / 05:25PM GMT
Release Date Price: $32.39 (-5.93%)
Yigal Dov Nochomovitz
Citigroup Inc., Research Division - Director

Great. Welcome, everyone. I'm Yigal Nochomovitz, one of the biotech analysts here at Citi. Welcome to the Arcus Biosciences fireside chat, and it's my pleasure to have with me several distinguished guests. First, the CEO, Terry Rosen; second, the Chief Operating Officer, Jennifer Jarrett; and the President of Research, Juan Jaen. So welcome all of you. Thank you very much for your participation.

Questions & Answers

Yigal Dov Nochomovitz
Citigroup Inc., Research Division - Director

And Terry, maybe just to kick things off and level set for those a little bit less familiar with the Arcus story. Maybe you could just walk us through the broad strategy of the company at a high level and what's the near-term mission of the company and what you see as the more longer-term mission.

Terry J. Rosen
Arcus Biosciences, Inc. - Co-Founder, Chairman & CEO

Sure. Thanks, Yigal. And thank you, everybody, for joining. We appreciate the interest. So I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot